First human test for hepatitis b drug in kidney patients
NCT ID NCT07342881
Summary
This early-stage study is testing a new drug called pevifoscorvir sodium for chronic hepatitis B. It aims to see how the drug is processed by the body and if it is safe for people with varying levels of kidney function. The study will enroll about 30 adults, comparing those with kidney problems to healthy participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Genesis Clinical Trials
RECRUITINGTampa, Florida, 33603, United States
Contact Email: •••••@•••••
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.